Switch from selegiline to rasagiline is beneficial in patients with Parkinson's disease. [electronic resource]
Producer: 20131105Description: 761-5 p. digitalISSN:- 1435-1463
- Aged
- Amphetamine -- blood
- Antiparkinson Agents -- therapeutic use
- Drug Substitution -- methods
- Female
- Humans
- Indans -- therapeutic use
- Male
- Methamphetamine -- blood
- Middle Aged
- Motor Activity -- drug effects
- Neuroprotective Agents
- Parkinson Disease -- blood
- Selegiline -- therapeutic use
- Severity of Illness Index
- Time Factors
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.